Viking Therapeutics, Inc. - VKTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 07, 2026 | — | A | A | 40,800.0 | 0.0 | 0.0 | 40,800.0 | View | |
| Aug 07, 2026 | — | A | A | 6,333.0 | 0.0 | 0.0 | 6,333.0 | View | |
| Jul 29, 2026 | President & CEO | S | D | 148,517.0 | 33.3153 | 4,947,888.41 | 2,572,441.0 | View | |
| Jul 29, 2026 | President & CEO | A | A | 221,667.0 | 0.0 | 0.0 | 2,720,958.0 | View | |
| Jul 29, 2026 | Chief Financial Officer | S | D | 21,217.0 | 33.4704 | 710,141.48 | 212,204.0 | View | |
| Jul 29, 2026 | Chief Financial Officer | A | A | 31,667.0 | 0.0 | 0.0 | 233,421.0 | View | |
| Jul 29, 2026 | Chief Operating Officer | S | D | 18,217.0 | 33.4652 | 609,635.55 | 422,760.0 | View | |
| Jul 29, 2026 | Chief Operating Officer | A | A | 31,667.0 | 0.0 | 0.0 | 440,977.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | A | A | 190,000.0 | 0.0 | 0.0 | 190,000.0 | View |